[
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_14",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_14",
        "immunotherapy_type": null,
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_14",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_15",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tisagenlecleucel",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_15",
        "immunotherapy_type": null,
        "drug_name": "Daratumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_15",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Obinutuzumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_16",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Encorafenib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_16",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_17",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_17",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Daratumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_18",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ado-trastuzumab emtansine",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 83
    }
]